Performance metrics for evaluating system suitability in liquid chromatography—Mass spectrometry peptide mass mapping of protein therapeutics and monoclonal antibodies-Reference-Cited by-同舟云学术

Performance metrics for evaluating system suitability in liquid chromatography—Mass spectrometry peptide mass mapping of protein therapeutics and monoclonal antibodies

Published:2015-07-28 Issue:6 Volume:7 Page:1104-1117
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Zhou Mowei,Gucinski Ashley C,Boyne Michael T

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/19420862.2015.1074364

Reference34 articles.

1. Characterization of Therapeutic Antibodies and Related Products

2. Mass spectrometry for structural characterization of therapeutic antibodies

3. Precision proteomics: The case for high resolution and high mass accuracy

4. Proteoform: a single term describing protein complexity

5. Evaluation of Intact Mass Spectrometry for the Quantitative Analysis of Protein Therapeutics

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Filling the gaps in peptide maps with a platform assay for top‐down characterization of purified protein samples;PROTEOMICS;2024-07-14

2. Qualification of a LC-HRMS platform method for biosimilar development using NISTmab as a model;Analytical Biochemistry;2024-05

3. Method validation and new peak detection for the liquid chromatography-mass spectrometry multi-attribute method;Journal of Pharmaceutical and Biomedical Analysis;2023-09

4. Establishing Quality Control Procedures for Large-Scale Plasma Proteomics Analyses;Journal of the American Society for Mass Spectrometry;2023-05-10

5. LC-MS Based Peptide Mapping Method Validation for Identifying Monoclonal Antibodies Using NistmNISTmab ab as Model;2023